Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Substance Abuse|May 27, 2003
Smoking cessation, smoking reduction, and delayed quitting among smokers given nicotine patches and a self-help pamphletDenise G Jolicoeur, Kimber P Richter, Jasjit S Ahluwalia, et al.
The Journal of Nursing Administration|April 25, 2014
The Affordable Health Care Act annual wellness visits: the effectiveness of a nurse-run clinic in promoting adherence to mammogram and colonoscopy recommendationsTheresa M Tetuan, Ruth Ohm, Matthew H Herynk, et al.
Substance Abuse|June 29, 2005
Cigarette smoking among marijuana users in the United StatesKimber P Richter, Haroshena Kaur, Ken Resnicow, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 8, 2003
Smoking reduction practices among African American smokersKolawole S Okuyemi, Kimber P Richter, Jasjit S Ahluwalia, et al.
Journal of the American Geriatrics Society|May 25, 2002
Impact of geographic barriers on the utilization of mammograms by older rural womenKimberly K Engelman, Daniel B Hawley, Rona Gazaway, et al.
Ethnicity & Disease|March 9, 2004
Differences in smoking and quitting experiences by levels of smoking among African AmericansKolawole S Okuyemi, Jasjit S Ahluwalia, Rachel Banks, et al.
Journal of Neuroimmunology|October 4, 2005
Statistical analysis of data from studies on experimental autoimmune encephalomyelitisKandace K Fleming, James A Bovaird, Michael C Mosier, et al.
Journal of American College Health : J of ACH|December 2, 2004
Healthcare providers' treatment of college smokersJennifer Scott Koontz, Kari Jo Harris, Kolawole S Okuyemi, et al.
Cancer Management and Research|June 6, 2017
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trialIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Future Oncology (London, England)|March 22, 2016
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapyIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Pageof 3